INTRAROSA: payments to doctors
Payments that named INTRAROSA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $882K
- Providers
- 12,760
- Transactions
- 31,259
- Average per transaction
- $28
The per-transaction average — $28 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12,760 providers the average total is $69, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AMAG Pharmaceuticals, Inc. | $590,274 | 66.9% |
| Millicent US Inc | $291,675 | 33.1% |